SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615219-18-000018
Filing Date
2018-03-07
Accepted
2018-03-07 16:39:18
Documents
85
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flks2017123110-k.htm 10-K 1984847
2 EXHIBIT 23.1 flks20171231ex-231.htm EX-23.1 8232
3 EXHIBIT 31.1 flks20171231ex-311.htm EX-31.1 10968
4 EXHIBIT 31.2 flks20171231ex-312.htm EX-31.2 11012
5 EXHIBIT 32.1 flks20171231ex321.htm EX-32.1 9327
12 figure1a04.jpg GRAPHIC 42003
13 figure2a07.jpg GRAPHIC 72989
  Complete submission text file 0001615219-18-000018.txt   7859562

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flks-20171231.xml EX-101.INS 1536341
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20171231.xsd EX-101.SCH 41724
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20171231_cal.xml EX-101.CAL 82000
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20171231_def.xml EX-101.DEF 214046
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20171231_lab.xml EX-101.LAB 647398
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20171231_pre.xml EX-101.PRE 401944
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36812 | Film No.: 18673804
SIC: 2834 Pharmaceutical Preparations